BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 14704746)

  • 1. Inflammatory pathways and insulin action.
    Hotamisligil GS
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S53-5. PubMed ID: 14704746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes.
    Hotamisligil GS
    Diabetes; 2005 Dec; 54 Suppl 2():S73-8. PubMed ID: 16306344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implication of MAP kinases in obesity-induced inflammation and insulin resistance].
    Ceppo F; Jager J; Berthou F; Giorgetti-Peraldi S; Cormont M; Bost F; Tanti JF
    Biol Aujourdhui; 2014; 208(2):97-107. PubMed ID: 25190570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and endoplasmic reticulum stress in obesity and diabetes.
    Hotamisligil GS
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7(Suppl 7):S52-4. PubMed ID: 19136991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK: bridging the insulin signaling and inflammatory pathway.
    Liu G; Rondinone CM
    Curr Opin Investig Drugs; 2005 Oct; 6(10):979-87. PubMed ID: 16259218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.
    Tanti JF; Jager J
    Curr Opin Pharmacol; 2009 Dec; 9(6):753-62. PubMed ID: 19683471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun N-terminal kinase pathways in diabetes.
    Yang R; Trevillyan JM
    Int J Biochem Cell Biol; 2008; 40(12):2702-6. PubMed ID: 18678273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
    Reinhard C; Shamoon B; Shyamala V; Williams LT
    EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress.
    Karalis KP; Giannogonas P; Kodela E; Koutmani Y; Zoumakis M; Teli T
    FEBS J; 2009 Oct; 276(20):5747-54. PubMed ID: 19754872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes.
    Vázquez-Carballo A; Ceperuelo-Mallafré V; Chacón MR; Maymó-Masip E; Lorenzo M; Porras A; Vendrell J; Fernández-Veledo S
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(1):E101-12. PubMed ID: 23651848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of inflammation in the development of insulin resistance in type 2 diabetes].
    Usui I; Tobe K
    Nihon Rinsho; 2011 Mar; 69(3):555-62. PubMed ID: 21400856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
    Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
    Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model.
    Sishi B; Loos B; Ellis B; Smith W; du Toit EF; Engelbrecht AM
    Exp Physiol; 2011 Feb; 96(2):179-93. PubMed ID: 20952489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
    Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
    Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
    Moller DE; Berger JP
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.